The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma

The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma

Objective: In this post-hoc analysis, we evaluated anlotinib treatment-induced hypertension as a potential predictive factor of efficacy in esophageal squamous cell carcinoma (ESCC) patients. Methods: A total of 109 patients enrolled in the anlotinib group in a phase 2 trial were included. The tumor...

Full description

Bibliographic Details
Main Authors: Yan Song, Juxiang Xiao, Wentao Fang, Ping Lu, Qingxia Fan, Yongqian Shu, Jifeng Feng, Shu Zhang, Yi Ba, Yang Zhao, Ying Liu, Chunmei Bai, Yuxian Bai, Yong Tang, Jie He, Jing Huang
Format: Article
Language:English
Published: China Anti-Cancer Association 2021-05-01
Series:Cancer Biology & Medicine
Subjects:
esophageal squamous cell carcinoma (escc)
anlotinib
treatment-induced hypertension
prognostic predictor
antiangiogenesis
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1828

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/1828

Similar Items